Permanent alopecia after busulfan chemotherapy
- 1 May 2005
- journal article
- case report
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 152 (5) , 1056-1058
Abstract
Systemic chemotherapy is a well known cause of reversible hair loss. Busulfan chemotherapy, however, is responsible for a permanent alopecia that usually occurs in bone marrow transplant patients. We report two patients with permanent alopecia due to busulfan chemotherapy. Both patients had a diffuse alopecia characterized by greatly reduced hair density with short, thin hair. The pathology showed reduced follicular density in the absence of fibrosis, suggesting that alopecia may result either from hair follicle stem cell destruction or from acute damage to the keratinocytes of the lower portion of some follicles.Keywords
This publication has 5 references indexed in Scilit:
- Permanent alopecia following chemotherapy and bone marrow transplantationAustralasian Journal of Dermatology, 2000
- Chronic telogen effluvium: Increased scalp hair shedding in middle-aged womenJournal of the American Academy of Dermatology, 1996
- Pulmonary complications of bone marrow transplantation: A comparison of total body irradiation and cyclophosphamide to busulfan and cyclophosphamideInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995
- The toxicity of busulphan and cyclophosphamide as the preparative regimen for bone marrow transplantationBritish Journal of Haematology, 1991
- The flag sign of chemotherapyCancer, 1983